Physician

Jared R Manning, MD

According to 2025 Medicare claims, Jared Manning, MD (NPI: 1326209701) practices hematology/oncology in the Logan, UT-ID market, with the plurality of this provider's patient population coming from Cache, UT. This provider's primary affiliated billing organization is IHC HEALTH SERVICES INC (NPI: 1033572193; TIN: 942854057) and primary practice location at 84341-6988. Manning is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Manning's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 655 HCPCS/CPT codes, and received $53,741 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 604 prescription claims across 164 beneficiaries totaling $484,419 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 23 claims. Open Payments data shows 2 records totaling $49. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $1,259,127 to $484,419. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,543 to $1,597.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	293	1,112	$51,542
2016	337	1,194	$52,646
2017	386	1,244	$56,030
2018	368	1,171	$50,523
2019	387	1,155	$52,894
2020	360	1,007	$47,973
2021	384	1,069	$73,774
2022	369	968	$72,612
2023	371	720	$52,945
2024	246	655	$53,741

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	134	986	$1,259,127
2016	169	1,113	$1,936,709
2017	182	1,242	$2,546,495
2018	188	1,353	$4,222,358
2019	220	1,479	$4,935,252
2020	206	1,264	$4,549,169
2021	209	1,424	$5,178,952
2022	204	1,327	$5,992,248
2023	237	1,100	$3,879,238
2024	164	604	$484,419

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	115	$49,518
2016	12	126	$34,045
2017	N/R	101	$19,443
2018	N/R	51	$9,607
2019	N/R	36	$3,993
2020	N/R	N/R	N/R
2021	N/R	42	$1,511
2022	N/R	15	$512
2023	N/R	23	$749
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	56	56	$161
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	51	72	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	147	318	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	85	$60
36415	Insertion of needle into vein for collection of blood sample	61	90	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	16	480	$9,612
Imatinib Mesylate	Imatinib Mesylate	19	570	$4,501
Abiraterone Acetate	Abiraterone Acetate	17	510	$2,373
Ondansetron Odt	Ondansetron	53	535	$832
Letrozole	Letrozole	55	2,410	$781

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$49	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jared R. Manning, MD?

Tedicare shows public-source Medicare data for Jared R. Manning, MD (NPI 1326209701), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jared R. Manning, MD have ACO affiliation data?

Jared R. Manning, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Jared R. Manning, MD?

Jared R. Manning, MD is linked to IHC HEALTH SERVICES INC (billing NPI 1033572193) in the available physician profile data.

Does Jared R. Manning, MD have Open Payments data?

Jared R. Manning, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.